Singular Genomics Systems downgraded by BofA Securities with a new price target
$OMIC
Biotechnology: Laboratory Analytical Instruments
Industrials
BofA Securities downgraded Singular Genomics Systems from Buy to Underperform and set a new price target of $3.00